BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32219138)

  • 1. Risk Factors for Brain Metastases in Patients with Renal Cell Carcinoma.
    Ke ZB; Chen SH; Chen YH; Wu YP; Lin F; Xue XY; Zheng QS; Xu N; Wei Y
    Biomed Res Int; 2020; 2020():6836234. PubMed ID: 32219138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.
    Sun M; De Velasco G; Brastianos PK; Aizer AA; Martin A; Moreira R; Nguyen PL; Trinh QD; Choueiri TK
    Eur Urol Focus; 2019 May; 5(3):474-481. PubMed ID: 29311016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based evaluation of the risk factors and prognosis among renal cell carcinoma patients with initially diagnosed lung metastases.
    Zhang Z; Liang C; Hou B; Zhou L
    Actas Urol Esp (Engl Ed); 2021 Sep; 45(7):498-506. PubMed ID: 34332926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and Validation of a Machine Learning Prediction Model Based on Big Data for Predicting the Risk of Bone Metastasis in Renal Cell Carcinoma Patients.
    Xu C; Liu W; Yin C; Li W; Liu J; Sheng W; Tang H; Li W; Zhang Q
    Comput Math Methods Med; 2022; 2022():5676570. PubMed ID: 36226243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data.
    Guðmundsson E; Hellborg H; Lundstam S; Erikson S; Ljungberg B;
    Eur Urol; 2011 Nov; 60(5):975-82. PubMed ID: 21741160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologica Epidemiological Characteristics and Change Tendencies of Renal Cell Carcinoma in Shanxi Province of China from 2005 to 2014.
    Bai T; Wang L; Wang D; Yuan X; Bai W; Yang Q; Yang X
    PLoS One; 2015; 10(12):e0144246. PubMed ID: 26633179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of bone metastasis and factors contributing to its development and prognosis in newly diagnosed renal cell carcinoma: a population-based study.
    Guo Q; Zhang C; Guo X; Tao F; Xu Y; Feng G; Han X; Ren Z; Zhang H; Zhang P; Wang X; Wang G
    Cancer Manag Res; 2018; 10():2935-2944. PubMed ID: 30214288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone Metastasis in Renal Cell Carcinoma Patients: Risk and Prognostic Factors and Nomograms.
    Fan Z; Huang Z; Huang X
    J Oncol; 2021; 2021():5575295. PubMed ID: 34054954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and Validation of a Convenient Clinical Nomogram to Predict the Risk of Brain Metastasis in Renal Cell Carcinoma Patients.
    Tong Y; Huang Z; Hu C; Chi C; Lv M; Song Y
    Biomed Res Int; 2020; 2020():9501760. PubMed ID: 33282957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinoma.
    Vogl UM; Bojic M; Lamm W; Frischer JM; Pichelmayer O; Kramer G; Haitel A; Kitz K; Harmankaya K; Zielinski CC; Schmidinger M
    BMC Cancer; 2010 Sep; 10():480. PubMed ID: 20819239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
    Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
    BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume.
    Ali MA; Hirshman BR; Wilson B; Schupper AJ; Joshi R; Proudfoot JA; Goetsch SJ; Alksne JF; Ott K; Aiyama H; Nagano O; Carter BS; Chiang V; Serizawa T; Yamamoto M; Chen CC
    World Neurosurg; 2017 Dec; 108():151-156. PubMed ID: 28754641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of laterality in renal cell carcinoma: A population-based study from the surveillance, epidemiology, and end results (SEER) database.
    Guo S; Yao K; He X; Wu S; Ye Y; Chen J; Wu CL
    Cancer Med; 2019 Sep; 8(12):5629-5637. PubMed ID: 31407495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of locally advanced and metastatic disease in patients with small renal masses.
    Kates M; Korets R; Sadeghi N; Pierorazio PM; McKiernan JM
    BJU Int; 2012 May; 109(10):1463-7. PubMed ID: 21933329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do renal cell carcinoma patients with brain metastases still need nephrectomy?
    Zhuang W; Li Y; Chen P; Wang J; Liu W; Chen J
    Int Urol Nephrol; 2019 Jun; 51(6):941-949. PubMed ID: 30953259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinoma.
    Du Y; Pahernik S; Hadaschik B; Teber D; Duensing S; Jäger D; Hohenfellner M; Grüllich C
    J Neurooncol; 2016 Oct; 130(1):221-228. PubMed ID: 27538910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk and prognostic factors of brain metastasis in lung cancer patients: a Surveillance, Epidemiology, and End Results population‑based cohort study.
    Hao Y; Li G
    Eur J Cancer Prev; 2023 Sep; 32(5):498-511. PubMed ID: 36804864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and pathological analysis of small renal cell carcinoma].
    Zhang XP; Huang ZX; Yu LP; Zhang XW; Li Q; Liu SJ; Xu T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):623-627. PubMed ID: 31420611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological characteristics and outcomes of synchronous renal cell carcinoma and urothelial carcinoma: A population-based analysis.
    Wu K; Liu X; Wang Y; Wang X; Li X
    Front Public Health; 2022; 10():994351. PubMed ID: 36388369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.